HCM

Hutchison China MediTech Limited

Price

$12.42

return (12m)

-16.98%

p/e

4.35

p/bv

1.65

DIVIDEND YIELD

0.00%

HCM price

Hutchison China MediTech

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment HCM

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

8.95%

3 months

8.42%

1 year

-16.98%

2 years

-28.29%

5 years

-67.41%

10 years

900.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals HCM

Valuation

P/E

4.35

Sector -0.28

Industry 2.77

P/BV

1.65

Sector 1.94

Industry 2.37

P/Revenue (PSR)

1.83

Sector 1.67

Industry 1.97

EV/EBITDA

101.31

Sector -55.30

Industry -73.25

EV/EBIT

924.62

Sector -488.87

Industry -73.47

P/EBITDA

3.78

Sector -185.04

Industry -262.99

P/EBIT

3.96

Sector -222.22

Industry -268.43

P/Total Assets

1.21

Sector 0.92

Industry 1.07

P/Net Current Assets

1.93

Sector -479.54

Industry -5.25

P/Working Capital

1.65

Sector -957.77

Industry 3.11

EPS

2.80

Sector -0.78

Industry -0.61

BVPS

7.37

Sector 3.74

Industry 4.57

Efficiency

Gross Margin

42.91%

Sector 48.28%

Industry 50.49%

EBITDA Margin

2.85%

Sector -5,407,515.68%

Industry -10.73%

EBIT Margin

0.31%

Sector -62.93%

Industry -21.31%

Operating Margin

-4.16%

Sector -23.12%

Industry -27.36%

Net Profit Margins

42.11%

Sector -27.40%

Industry -30.91%

Asset Turnover

0.16

Sector 0.13

Industry 0.15

Profitability

ROE

38.02%

Sector -31.88%

Industry -27.86%

ROA

27.92%

Sector -28.23%

Industry -27.56%

ROIC

0.38%

Sector -315.71%

Industry -57.09%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

5.64

Sector 1.85

Industry 1.98

Net Debt / EBITDA

-164.07

Sector -42.46

Industry -72.45

Net Debt / EBIT

-1,497.38

Sector -37.26

Industry -7.11

Net Debt / Equity

-1.02

Sector -1.04

Industry -0.12

Gross Debt / Equity

0.06

Sector -0.72

Industry 0.10

Equity/Assets

0.73

Sector 0.43

Industry 0.45

Liabilities/Assets

0.27

Sector 0.48

Industry 0.51

Growth

5Y Revenue CAGR

26.45%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF Hutchison China MediTech ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$12.42

Fair Value

$21.55

Upside Return potential.

73.49%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals HCM

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
HCM Hutchison China MediTech Limited	$12.42	-20.54%	0.00%	4.35	1.65	38.02%	42.11%
LLY Eli Lilly and Compay	$1,176.10	62.05%	0.52%	41.58	-	-%	33.53%
SNY Sanofi	$44.84	-7.34%	3.87%	7.43	1.37	18.43%	13.81%
GSK GlaxoSmithKline PLC	$50.27	32.02%	3.42%	15.92	4.50	28.24%	14.54%
CRMD CorMedix Inc.	$8.31	-40.60%	0.00%	3.45	1.40	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$21.88	-27.88%	0.00%	12.05	1.23	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$12.16	-13.85%	0.68%	27.69	2.50	9.03%	10.14%
ISRG Intuitive Surgical Inc.	$367.07	-22.60%	0.00%	41.88	7.23	17.26%	28.62%
NVS Novartis AG	$154.65	24.49%	1.96%	28.21	7.75	27.47%	26.57%
TMO Thermo Fisher Scientific Inc.	$630.70	29.67%	0.29%	33.36	4.42	13.26%	15.08%
ABT Abbott Laboratories	$112.04	-12.82%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$89.97	1.55%	3.09%	24.60	2.36	9.59%	13.20%
BSX Boston Scientific Corp.	$47.36	-55.49%	0.00%	17.71	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$91.75	-20.34%	0.00%	21.60	6.32	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$545.08	-15.06%	0.00%	38.78	27.41	70.67%	25.03%
RMD ResMed Inc.	$235.76	-16.28%	1.04%	22.12	5.18	23.41%	27.44%
DHR Danaher Corporation	$215.68	5.84%	0.67%	37.88	2.88	7.61%	15.95%
HCA HCA Healthcare Inc.	$419.34	5.01%	0.70%	12.08	-29.56	-244.72%	10.07%
COHR Coherent Inc.	$293.54	220.52%	0.00%	115.66	4.75	4.11%	6.85%
PHG Koninklijke Philips NV	$26.93	0.63%	3.68%	20.31	1.99	9.80%	6.30%
SYK Stryker Corp.	$322.12	-17.26%	1.06%	33.67	5.23	15.55%	14.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

HCM Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Hutchison China MediTech

Hutchison China MediTech Limited

Average Investor10 user rating

4.0 (1 people)

China

26 years

Founded: 2000

2016

Time since IPO - 10 years

1.280

Employees

Hutchison China MediTech Limited (China) is listed on the Nasdaq and has a market capitalization of $2.11 billion, with shareholders equity totaling $1.27 billion.

The company employs approximately 1.280 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Hutchison China MediTech Limited reported $1.15 billion in revenue, generating net income of $484.77 million.

Key financial metrics include a P/E ratio of 4.35, a price-to-book (P/B) ratio of 1.65, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker HCM.

Market cap

$2.11 billion

Net worth

$1.27 billion

$1,274,970,000.00

Assets

$1.74 billion

$1,736,430,000.00

Total Shares Outstanding

173.00 million

173,000,000

Average Daily Trading Volume

$53.91 Thousand

$53,906.00

Sector

Health

Industry

Pharmaceutical Products

HCM

HCM revenue and profits

Financial Results HCM

DRAG THE FRAME TO SEE MORE DATA

HCM cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$92.92 32,87% (12M)

P/E

-0.84

2.83%

ROE

-178.93%

P/BV

1.51

CI - Cigna

$277.67 --4,55% (12M)

P/E

10.77

2.20%

ROE

16.04%

P/BV

1.73

CNC - Centene

$65.33 130,20% (12M)

P/E

-6.35

0.00%

ROE

-22.56%

P/BV

1.43

HUM - Humana

$392.63 33,71% (12M)

P/E

35.82

0.92%

ROE

6.72%

P/BV

2.41

SNY - Sanofi

$44.84 --6,67% (12M)

P/E

7.43

3.87%

ROE

18.43%

P/BV

1.37

LLY - Eli Lilly

$1,176.10 61,91% (12M)

P/E

41.58

0.52%

ROE

P/BV

HCA - HCA Healthcare

$419.34 3,64% (12M)

P/E

12.08

0.70%

ROE

-244.72%

P/BV

-29.56

NVS - Novartis

$154.65 24,62% (12M)

P/E

28.21

1.96%

ROE

27.47%

P/BV

7.75